Biodesix Inc. (NASDAQ:BDSX) is one of the best penny stocks under $1 to buy now. On June 10, Biodesix announced a new ...

Across four prospective U.S. cohorts, 4.5% of those 18-49 years old met criteria for COPD, defined as spirometric airflow ...

SINGAPORE – Vapes, e-cigarettes, dab pens, pod-mods, and vaporisers – whatever they are called, an increasing number of ...

A new study has found that patients with metastatic non–small cell lung cancer and pre-existing rheumatoid arthritis have similar overall survival to those without RA when treated with immune ...

Every-other-year screening starting at age 50, followed by annual screening once reaching 60 years of age, would result in 20 ...

Topline data were announced from two phase 3 trials evaluating astegolimab in patients with moderate to very severe COPD.

We take around 20,000 breaths a day, yet rarely pause to think about the organs that make it all possible our lungs. Quietly ...

If you thought only smokers get lung cancer think again here’s what could be silently putting non-smokers at risk ...

LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit, is proud to announce its participation in the 2025 LungXperience Tour, a national mobile health initiative created in ...

A 36-year-old woman with recurrent pneumothorax and no clear risk factors is found to have a rare inherited syndrome, diagnosed only through genetic testing.

It's shaping up to be a big year for Boehringer Ingelheim—at least if the FDA plays ball. | Boehringer Chief Medical Officer Lykke Hinsch Gylvin, M.D., set out the German drugmaker's plans to launch ...

University of British Columbia Okanagan researchers are hoping their recent findings can help treat various health conditions ...